Presentation TCT 2018 Assessing Chest Pain With Invasive Physiology: Lessons From Orbita and Other Studies Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee September 24, 2018
Presentation TCT 2018 Physiology Case Vignette #8: IMR Made the Diagnosis! Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee, Giuseppe De Luca, Ole Fröbert, Zsolt Piroth, Afzalur Rahman, Tim P. Van de Hoef September 24, 2018
Presentation TCT 2018 Physiology Case Vignette #7: Combined Pressure/Flow in Practice Presenter: Morton J. Kern, Jan J. Piek, Rasha Al-Lamee, Giuseppe De Luca, Ole Fröbert, Zsolt Piroth, Afzalur Rahman, Tim P. Van de Hoef September 24, 2018
Presentation TCT 2018 ORBITA in the Spotlight: How I Interpret ORBITA as an Interventional Cardiologist Presenter: Ajay J. Kirtane, Stuart J. Pocock, Rasha Al-Lamee September 23, 2018
Presentation TCT 2018 ORBITA One Year Later: What Would I Do Differently, If Anything? Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee September 23, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
Presentation EuroPCR 2018 ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease Presenter: Rasha Al-Lamee May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
Presentation Intravascular Coronary Imaging and Physiology 2018 Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow Presenter: Rasha Al-Lamee May 06, 2018
Presentation Intravascular Coronary Imaging and Physiology 2018 PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA Presenter: Rasha Al-Lamee May 05, 2018
Podcast TCTMD Talking Points ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease May 02, 2018
News Conference News SCAI 2018 ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended L.A. McKeown April 26, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018